You have 9 free searches left this month | to do more

Fludarabine

Fludarabine is a drug used to treat Leukemia, Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and other conditions. Fludarabine is being actively studied in 317 studies and prior, has been studied in 198.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterNational Institutes of Health Clinical Center, 9000 Rockville PikeSteven Rosenberg, M.D.
National Cancer Institute (NCI)University of Texas MD Anderson Cancer CenterRichard Burt, MD
Baylor College of MedicineMemorial Sloan Kettering Cancer CenterRobert Krance
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-03-01
Mar 1, 2022
U
Completed
  • Hematologic Malignancies
  • +7 more
  • Fludarabine
  • San Francisco, California
    University of California, San Francisco
2021-09-27
Sep 27, 2021
N
Active, not recruiting
  • Adult T-Cell Leukemia (ATL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-13
Jan 13, 2022
N
Terminated
  • Acute Myeloid Leukemia
  • +3 more
  • Fludarabine
  • Total Marrow Irradiation (TMI)
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
2022-02-22
Feb 22, 2022
M
Completed
  • Disorder Related to Bone Marrow Transplantation
  • +2 more
  • Fludarabine
  • +6 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021
N
Completed
  • Aplastic Anemia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-06-07
Jun 7, 2021
S
Recruiting
  • Leukemia, Acute Lymphoblastic
  • +5 more
  • Fludarabine
  • +5 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2021-06-21
Jun 21, 2021
U
Recruiting
  • Acute Myeloid Leukemia, Adult
  • +2 more
  • La Jolla, California
    UCSD Moores Cancer Center
2021-03-30
Mar 30, 2021
M
Recruiting
  • Hematologic Malignancies
  • Busulfan 3.2 mg/kg/day
  • +5 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2022-03-14
Mar 14, 2022
S
Recruiting
  • Myelogenous Leukemia, Acute
  • Ramat Gan, Israel
    Chaim Sheba Medical Center
2021-09-21
Sep 21, 2021
M
Recruiting
  • Hematological Malignancy
  • +3 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
2021-05-25
May 25, 2021
C
Recruiting
  • Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
2022-01-24
Jan 24, 2022
C
Recruiting
  • Sickle Cell Disease
  • +2 more
  • Fludarabine
  • Hematopoietic Stem Cell Transplant (HSCT)
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
2021-07-06
Jul 6, 2021
U
Active, not recruiting
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
2021-04-11
Apr 11, 2021
U
Active, not recruiting
  • Adult Lymphoblastic Lymphoma
  • Fludarabine
  • Total Body Irradiation
  • Birmingham, Alabama
    UAB Bone Marrow Transplantation and Cellular Therapy Program
2021-06-24
Jun 24, 2021
H
Active, not recruiting
  • Sickle Cell Disease
  • Hackensack, New Jersey
    Hackensack University Medical Center
2022-02-04
Feb 4, 2022
M
Completed
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
2020-09-22
Sep 22, 2020
W
Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Morgantown, West Virginia
    West Virginia University Hospitals Mary Babb Randolph Cancer Cen
2021-04-06
Apr 6, 2021
M
Active, not recruiting
  • B-Lymphoid Malignancies
  • +3 more
  • Fludarabine
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-18
Nov 18, 2021
M
Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-12
Nov 12, 2021
I
Completed
  • Cancer
  • Solid Tumor
  • Fludarabine
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-01-14
Jan 14, 2022
M
Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-01-12
Jan 12, 2021
S
Recruiting
  • Hematological Malignancies
  • Total Body Irradiation
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2022-02-04
Feb 4, 2022
M
Completed
  • Lymphoma
  • Fludarabine
  • +4 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-02-15
Feb 15, 2021